Evidence Hub

The Influence of Falsely Low HbA1c Levels in Diabetes Patients With Hereditary Hemorrhagic Telangiectasia: The Need for Alternative Diagnostic Approaches

Foley O, Tauseef A, Brenner J

WMJ : official publication of the State Medical Society of Wisconsin, 2026

Abstract

Introduction: Hereditary hemorrhagic telangiectasia (HHT) causes various age-related symptoms, including epistaxis, telangiectasia, and anemia. These symptoms often require a variety of treatments, including iron supplementation and blood transfusions. The resulting anemia can lead to atypical presentations of comorbidities, such as diabetes.

Case presentation: A 46-year-old Hispanic woman with a history of HHT presented for diabetes evaluation due to asymptomatic, elevated nonfasting blood glucose despite normal hemoglobin A1c (HbA1c) levels. Following initiation of continuous glucose monitoring and metformin (500 mg twice daily), her blood glucose levels improved significantly.

Discussion: Patients with HHT are more likely to develop iron deficiency anemia and anemia secondary to chronic blood loss, rendering HbA1c levels unreliable for diagnosing diabetes.

Conclusions: Clinicians should consider the impact of HHT-related anemia when monitoring patients for diabetes. Alternative diagnostic methods are necessary to prevent delays in diagnosis and treatment.

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free